JP2007527873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007527873A5 JP2007527873A5 JP2007501960A JP2007501960A JP2007527873A5 JP 2007527873 A5 JP2007527873 A5 JP 2007527873A5 JP 2007501960 A JP2007501960 A JP 2007501960A JP 2007501960 A JP2007501960 A JP 2007501960A JP 2007527873 A5 JP2007527873 A5 JP 2007527873A5
- Authority
- JP
- Japan
- Prior art keywords
- copolymer
- copolymer composition
- hla
- amino acid
- glutamic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54940904P | 2004-03-01 | 2004-03-01 | |
| US55139604P | 2004-03-09 | 2004-03-09 | |
| PCT/US2005/006822 WO2005085323A2 (en) | 2004-03-01 | 2005-03-01 | Methods and compositions for treatment of autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011162044A Division JP2012001547A (ja) | 2004-03-01 | 2011-07-25 | 自己免疫疾患の治療のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007527873A JP2007527873A (ja) | 2007-10-04 |
| JP2007527873A5 true JP2007527873A5 (https=) | 2008-04-17 |
Family
ID=34922714
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501960A Withdrawn JP2007527873A (ja) | 2004-03-01 | 2005-03-01 | 自己免疫疾患の治療のための方法および組成物 |
| JP2011162044A Pending JP2012001547A (ja) | 2004-03-01 | 2011-07-25 | 自己免疫疾患の治療のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011162044A Pending JP2012001547A (ja) | 2004-03-01 | 2011-07-25 | 自己免疫疾患の治療のための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080194462A1 (https=) |
| EP (1) | EP1725603A2 (https=) |
| JP (2) | JP2007527873A (https=) |
| KR (1) | KR20060125916A (https=) |
| AU (1) | AU2005219876A1 (https=) |
| BR (1) | BRPI0508382A (https=) |
| CA (1) | CA2558655A1 (https=) |
| IL (1) | IL177849A0 (https=) |
| MX (1) | MXPA06010043A (https=) |
| NO (1) | NO20064389L (https=) |
| NZ (1) | NZ549731A (https=) |
| RU (1) | RU2006134701A (https=) |
| WO (1) | WO2005085323A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8378072B2 (en) | 2006-04-13 | 2013-02-19 | Declion Pharmaceuticals, Inc. | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability |
| ES2565035T3 (es) | 2006-04-28 | 2016-03-30 | Momenta Pharmaceuticals, Inc. | Métodos para evaluar mezclas de péptidos |
| WO2008110206A1 (en) * | 2007-03-13 | 2008-09-18 | Genome Diagnostics B.V. | Method for determining a hla-dq haplotype in a subject |
| AP3467A (en) | 2007-10-16 | 2015-11-30 | Peptimmune Inc | Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
| WO2009128948A1 (en) | 2008-04-17 | 2009-10-22 | Peptimmune, Inc. | Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| WO2010141883A1 (en) * | 2009-06-04 | 2010-12-09 | The Regents Of The University Of Colorado | Compounds that modulate autoimmunity and methods of using the same |
| WO2011011706A2 (en) * | 2009-07-24 | 2011-01-27 | The Johns Hopkins University | Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| HUE060304T2 (hu) | 2010-01-04 | 2023-02-28 | Mapi Pharma Ltd | Glatiramer acetátot tartalmazó depó rendszer |
| US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| WO2012143924A1 (en) * | 2011-04-21 | 2012-10-26 | Mapi Pharma Ltd. | Random pentapolymer for treatment of autoimmune diseases |
| US9629848B2 (en) | 2011-05-26 | 2017-04-25 | The Regents Of The University Of Colorado, A Body Corporate | Compounds that modulate autoimmunity and methods of using the same |
| WO2014018763A2 (en) * | 2012-07-25 | 2014-01-30 | University Of Cincinnati | Method of treating type i diabetes using apolipoprotein aiv |
| EP3247384B1 (en) | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| WO2017165508A1 (en) * | 2016-03-24 | 2017-09-28 | Im Therapeutics | Methods of treating autoimmune disease |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| CN109982712A (zh) | 2016-08-31 | 2019-07-05 | Mapi医药公司 | 包含醋酸格拉替雷的储库系统 |
| US11965892B2 (en) | 2017-02-12 | 2024-04-23 | Biontech Us Inc. | HLA-based methods and compositions and uses thereof |
| CN110382052A (zh) | 2017-03-26 | 2019-10-25 | Mapi医药公司 | 用于治疗进展型形式的多发性硬化症的格拉替雷储库系统 |
| US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
| US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
| WO2020122609A1 (ko) * | 2018-12-11 | 2020-06-18 | 주식회사 인트론바이오테크놀로지 | 신규 화합물 및 이를 포함하는 신경계 질환 치료용 약학적 조성물 |
| EP3899039A4 (en) * | 2018-12-20 | 2022-09-14 | The Johns Hopkins University | TREATMENT OF TYPE 1 DIABETES, AND OTHER AUTOIMMUNE DISEASES |
| KR20240091046A (ko) * | 2018-12-21 | 2024-06-21 | 바이오엔테크 유에스 인크. | Hla 클래스 ii-특이적 에피토프 예측 및 cd4+ t 세포 특징화를 위한 방법 및 시스템 |
| WO2021026175A1 (en) * | 2019-08-05 | 2021-02-11 | Icahn School Of Medicine At Mount Sinai | Peptides that block presentation of antigenic islet peptides by hla-dq8 and methods for treating type-1 diabetes |
| CN120923775B (zh) * | 2025-10-13 | 2026-04-17 | 浙江大学 | 一种含有甘氨酸残基和脯氨酸残基的无规共聚物及其合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL36670A (en) * | 1971-04-21 | 1974-09-10 | Sela M | Therapeutic basic copolymers of amino acids |
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US5858964A (en) * | 1995-04-14 | 1999-01-12 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD |
| US6214791B1 (en) * | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| US6875451B2 (en) * | 1997-10-15 | 2005-04-05 | Polarx Biopharmaceuticals Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| DK2239269T3 (da) * | 1998-09-25 | 2013-04-29 | Yeda Res & Dev | Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører |
| JP4328050B2 (ja) * | 2000-01-20 | 2009-09-09 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 神経保護療法のためのコポリマー１、関連ペプチド及びポリペプチドならびにそれらによって処理されたｔ細胞の使用 |
| EP1188433B1 (en) * | 2000-09-14 | 2007-01-03 | Firmenich Sa | Use of unsaturated esters as perfuming ingredients |
| DE02800437T1 (de) * | 2001-10-03 | 2004-11-11 | The President And Fellows Of Harvard College, Cambridge | Copolymere zur unterdrückung von autoimmunkrankheiten und anwendungsverfahren |
| JP5495490B2 (ja) * | 2004-05-07 | 2014-05-21 | アレス トレーディング エスエイ | ランダム共重合体を用いる疾患の治療方法 |
| WO2006031727A2 (en) * | 2004-09-13 | 2006-03-23 | President And Fellows Of Harvard College | Peptides for treatment of autoimmune diseases |
-
2005
- 2005-03-01 AU AU2005219876A patent/AU2005219876A1/en not_active Abandoned
- 2005-03-01 EP EP05724381A patent/EP1725603A2/en not_active Withdrawn
- 2005-03-01 CA CA002558655A patent/CA2558655A1/en not_active Abandoned
- 2005-03-01 WO PCT/US2005/006822 patent/WO2005085323A2/en not_active Ceased
- 2005-03-01 JP JP2007501960A patent/JP2007527873A/ja not_active Withdrawn
- 2005-03-01 RU RU2006134701/04A patent/RU2006134701A/ru unknown
- 2005-03-01 KR KR1020067020488A patent/KR20060125916A/ko not_active Ceased
- 2005-03-01 NZ NZ549731A patent/NZ549731A/en unknown
- 2005-03-01 BR BRPI0508382-6A patent/BRPI0508382A/pt not_active IP Right Cessation
- 2005-03-01 MX MXPA06010043A patent/MXPA06010043A/es not_active Application Discontinuation
- 2005-09-15 US US10/591,315 patent/US20080194462A1/en not_active Abandoned
-
2006
- 2006-09-01 IL IL177849A patent/IL177849A0/en unknown
- 2006-09-28 NO NO20064389A patent/NO20064389L/no not_active Application Discontinuation
-
2011
- 2011-07-25 JP JP2011162044A patent/JP2012001547A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007527873A5 (https=) | ||
| RU2006134701A (ru) | Способы и композиции для лечения аутоиммунных заболеваний | |
| US8475779B2 (en) | Methods of treating disease with random copolymers | |
| JP5676079B2 (ja) | ランダムコポリマーによる不要な免疫応答の処置方法 | |
| TWI250021B (en) | Pharmaceutical composition for use in the treatment of an inflammatory autoimmune disease or condition | |
| JP2006514104A5 (https=) | ||
| JP2012255034A (ja) | ランダム共重合体を用いる疾患の治療方法 | |
| WO2015197193A2 (en) | New use for jnk inhibitor molecules for treatment of various diseases | |
| NO337092B1 (no) | Aminosyrekopolymerer for suppresjon av autoimmunsykdommer, preparat og enhetsdoseform samt deres anvendelse | |
| EP1534289B2 (en) | Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus | |
| CA2614171C (en) | Copolymers for suppression of autoimmune diseases, and methods of use | |
| WO2025172592A1 (en) | Alpha synuclein therapeutic vaccine | |
| Ünübol et al. | Peptides in Brain Disorders | |
| JP2026506882A (ja) | 神経学的障害を処置するためのペプチド | |
| JP2026503048A (ja) | ＮＥＴｏｓｉｓ媒介性疾患の治療方法 | |
| CA2768340A1 (en) | Copolymers for suppression of autoimmune diseases, and methods of use | |
| CN101014355A (zh) | 用于治疗自身免疫病的方法和组合物 |